Engineering adeno‐associated virus serotype 2‐based targeting vectors using a new insertion site‐position 453‐and single point mutations

Abstract

Position 453 emerged as a prominent site for the development of targeting mutants. Furthermore, we show for the first time that linearly distant residues can be critical for the efficiency of inserted peptide ligands.